Lung Cancer in Smokers, Nonsmokers May Be a Different
MONDAY, Nov. 8 (HealthDay News) -- New research suggests that
lung cancer in people who have never smoked may be a different
disease than it is in smokers.
Scientists compared the genetic characteristics of lung cancer
tumors in 30 people who never smoked to tumors in 53 smokers or
The tumors of people who had never smoked had twice as many DNA
abnormalities as people who were current or former smokers, said
study author Kelsie Thu, a doctoral candidate at the British
Columbia Cancer Research Centre in Vancouver.
"This is suggesting there might be something different going on with tumors in never-smokers," Thu said. "If we find out lung cancer in never-smokers is a different disease and we can identify what those differences are, maybe we can design specific therapies that target the genetic alterations in never-smokers and improve the prognosis."
The study was to be presented Monday at the American Association
of Cancer Research's annual conference, in Philadelphia.
Lung cancer is the leading cause of cancer deaths in the United
States for men and woman, according to the American Cancer Society.
Lung cancer will kill an estimated 157,000 Americans this year.
But it's not just smokers who get it -- lung cancer is the
seventh-leading cause of cancer deaths among people who have never
smoked, Thu said. Dana Reeve, wife of the late Christopher Reeve,
died in 2006 at age 44 from lung cancer. She had never smoked.
Prior research has hinted that lung cancer tumors in
never-smokers is different than the tumors in smokers. Compared to
former and current smokers with lung cancer, never-smokers with
lung cancer tend to be diagnosed younger, are more likely to be
women and are more likely to have adenocarcinomas, the most common
type of cancer. All of the lung cancer patients in the study had
People who never smoked are also more likely to have a mutation
in the epidermal growth factor receptor (EGFR) gene.
"All of those differences are evidence there may be something different going on with their tumors," Thu said.
The new study confirmed earlier findings that nonsmokers were
more likely to have the EGFR mutation, Thu said.
Never-smokers with lung cancer were also less likely to have the
KRAS mutation, which has also been shown in prior research.
In smokers, it's believed that the carcinogens in tobacco and
cigarettes cause DNA mutations that lead to the uncontrolled growth
of cancer cells, Thu said.
In nonsmokers, the added genetic mutations suggest other
mechanisms are driving the tumor growth, Thu said. "We hypothesize
there is more genomic instability in the never-smokers than the
smokers, and that leads us to believe there may be some other
molecular mechanism that is driving the tumor development," she
Dr. David Carbone, a professor of medicine and cancer biology at
Vanderbilt University, said the new study supports the idea that
cancer in people who've never smoked vs. current and former smokers
In never-smokers, the challenge is not only coming up with
treatments that target the genetic mutations of their tumor, but in
identifying people soon enough to help them, said Carbone, a member
of the Lung Cancer Foundation of America's scientific advisory
Nonsmokers tend to take longer to be diagnosed with lung cancer
because few suspect they have it, he said.
"We often see never-smokers present with advanced, incurable disease," he said.
Drugs that target particular genetic pathways have been very
successful. Erlotinib (Tarceva), for example, has been shown to
extend the lives of lung cancer patients with the EGFR mutation,
present in about 10 percent of lung cancers, Carbone said.
U.S. National Cancer Institute has more on lung
Copyright © 2010
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.